Background The aetiology of inflammatory bowel disease (IBD) remains poorly understood.
Recent evidence suggests an important role of gut microbial dysbiosis in IBD, and this may …

Diagnosing irritable bowel syndrome (IBS) can be a challenge; many clinicians resort to
invasive investigations in order to rule out other diseases and reassure their patients …

Volatile organic compounds (VOCs) are produced by the human metabolism, inflammation
and gut microbiota and form the basis of innovative volatomics research. VOCs detected …

Background Disappearance of macroscopic mucosal inflammation predicts long-term
outcome in Crohn's disease (CD). It can be assessed by ileocolonoscopy, which is …

Background Bacteria play a role in the onset and perpetuation of intestinal inflammation in
IBD. Compositional alterations may also change the metabolic capacities of the gut bacteria …

Abstract Background and Aims: Distinguishing between the inflammatory bowel diseases
[IBD], Crohn's disease [CD] and ulcerative colitis [UC], is important for determining …

Introduction Early inflammatory bowel disease (IBD) diagnosis remains a clinical challenge.
Volatile organic compounds (VOCs) have shown distinct patterns in Crohn's disease (CD) …

Background To optimise treatment of ulcerative colitis (UC), patients need repeated
assessment of mucosal inflammation. Current non‐invasive biomarkers and clinical activity …

This study employs spectroscopy-based metabolic profiling of fecal extracts from healthy
subjects and patients with active or inactive ulcerative colitis (UC) and Crohn's disease (CD) …

Abstract Background and Aims Inflammatory bowel disease (IBD) is a prevalent chronic
noncurable disease associated with profound metabolic changes. The discovery of novel …